Annual Drug Patent Expirations for ULORIC
Uloric is a drug marketed by Takeda Pharms Usa and is included in one NDA. It is available from one supplier. There are three patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for ULORIC.
This drug has twenty-five patent family members in fifteen countries.
The generic ingredient in ULORIC is febuxostat. One supplier is listed for this compound. Additional details are available on the febuxostat profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
